D55.29
Anemia due to other disorders of glycolytic enzymes
Clinical Classification Guidelines
Inclusion Terms
- Hexokinase deficiency anemia
- Triose-phosphate isomerase deficiency anemia
Medical Intelligence & Overview
Anemia due to other disorders of glycolytic enzymes, classified under ICD-10 code D55.29, is a rare form of anemia caused by deficiencies or malfunctions of specific enzymes involved in the glycolytic pathway within red blood cells. These enzymatic abnormalities impair the red blood cells' ability to produce energy efficiently, leading to their premature destruction or decreased production. This condition includes disorders such as hexokinase deficiency anemia and triose-phosphate isomerase deficiency anemia, both of which impact the normal functioning of red blood cells, resulting in anemia.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting glycolytic enzymes such as hexokinase or triose-phosphate isomerase Inherited deficiencies leading to reduced enzyme activity in red blood cells Rare enzyme malfunctions disrupting normal energy production in erythrocytes
Key Symptoms: Fatigue and weakness Pale skin or pallor Shortness of breath, especially during activity Rapid heartbeat or palpitations Jaundice, appearing as yellowing of the skin or eyes Dark-colored urine in some cases Splenomegaly, or enlarged spleen, due to increased red blood cell destruction
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of blood tests and specialized enzyme assays. Common steps include:
Treatment Protocols: Management of this type of anemia generally focuses on alleviating symptoms and preventing complications. Treatment strategies include:
Clinical Advice & FAQs
Billing Guidance
Is D55.29 a billable ICD-10 code?
Yes, D55.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D55.29?
Clinical documentation must specify the nature of Anemia due to other disorders of glycolytic enzymes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
